Publicacións nas que colabora con Fernando Luis Hernando Echevarría (17)

2023

  1. Dot Immunobinding Assay for the Rapid Serodetection of Scedosporium/Lomentospora in Cystic Fibrosis Patients

    Journal of Fungi, Vol. 9, Núm. 2

2021

  1. The host immune response to Scedosporium/Lomentospora

    Journal of Fungi, Vol. 7, Núm. 2, pp. 1-20

2020

  1. ELISA Test for the Serological Detection of Scedosporium/Lomentospora in Cystic Fibrosis Patients

    Frontiers in Cellular and Infection Microbiology, Vol. 10

  2. Identification of Mucor circinelloides antigens recognized by sera from immunocompromised infected mice

    Revista Iberoamericana de Micologia, Vol. 37, Núm. 3-4, pp. 81-86

  3. Melanin and pyomelanin in Aspergillus fumigatus: from its genetics to host interaction

    International microbiology: official journal of the Spanish Society for Microbiology, Vol. 23, Núm. 1, pp. 55-63

  4. The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Study of humoral responses against Lomentospora/scedosporium spp. And aspergillus fumigatus to identify L. prolificans antigens of interest for diagnosis and treatment

    Vaccines, Vol. 7, Núm. 4

2018

  1. Microglial immune response is impaired against the neurotropic fungus Lomentospora prolificans

    Cellular Microbiology, Vol. 20, Núm. 8

  2. Mikroorganismoek minbizia eragin dezakete?

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 34, pp. 9-28

  3. Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 1, pp. 10-15

  4. Proteomics as a Tool to Identify New Targets Against Aspergillus and Scedosporium in the Context of Cystic Fibrosis

    Mycopathologia, Vol. 183, Núm. 1, pp. 273-289

2017

  1. Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole

    PLoS ONE, Vol. 12, Núm. 3

2016

  1. Candida albicans and cancer: Can this yeast induce cancer development or progression?

    Critical Reviews in Microbiology, Vol. 42, Núm. 2, pp. 181-193

  2. Cyclophilin and enolase are the most prevalent conidial antigens of Lomentospora prolificans recognized by healthy human salivary IgA and cross-react with Aspergillus fumigatus

    Proteomics - Clinical Applications, Vol. 10, Núm. 9-10, pp. 1058-1067

  3. Immunoproteomics-Based Analysis of the Immunocompetent Serological Response to Lomentospora prolificans

    Journal of Proteome Research, Vol. 15, Núm. 2, pp. 595-607

2014

  1. Scedosporium prolificans immunomes against human salivary immunoglobulin A

    Fungal Biology, Vol. 118, Núm. 1, pp. 94-105

2013

  1. Candida albicans Increases Tumor Cell Adhesion to Endothelial Cells In Vitro: Intraspecific Differences and Importance of the Mannose Receptor

    PLoS ONE, Vol. 8, Núm. 1